TY - JOUR
T1 - Patterns of healthcare utilization by COPD severity
T2 - A pilot study
AU - Joo, Min J.
AU - Lee, Todd A.
AU - Bartle, Brian
AU - Van De Graaff, William B.
AU - Weiss, Kevin B.
N1 - Funding Information:
This study was partly funded by an unrestricted research grant from Boehringer-Ingelheim Pharmaceuticals. This material was also based upon work supported by the HSR&D Service, Center for Management of Complex Chronic Care COE, Hines VA Hospital. The funding agency had no role in the design, conduct, or interpretation of the study results. Kevin Weiss was the Director for the Management of Complex Chronic Care, Hines VA Hospital, Hines, IL, and the Institute for Healthcare Studies at Northwestern University Feinberg School of Medicine, Chicago, IL, when this work was performed. This work was performed while all authors were employees of the Hines Veterans Administration Hospital. As U.S. government employees, this article was made in that capacity, thus assignment applies only to the extent allowable by U.S. law.
PY - 2008/10
Y1 - 2008/10
N2 - Global Initiative on Chronic Obstructive Lung Disease (GOLD) guidelines recently removed stage 0, a group with symptoms but without airways obstruction, from their severity staging. However, in practice this group may still be diagnosed and medically managed. The aim of this study was to characterize healthcare utilization patterns of chronic obstructive pulmonary disease (COPD) patients by disease severity, focusing on the possible unique attributes of patients who would have been classified as GOLD stage 0. This is a prospective cohort pilot study performed at the Hines Veterans Administration Hospital. One hundred twenty patients with a diagnosis of COPD were enrolled. The participants completed quality-of-life questionnaires and a pulmonary function test. Healthcare utilization data were obtained 1 year prior and 2 years after the enrollment date. Three disease severity groups were defined based on GOLD criteria for comparison [GOLD stage 1-2 (GS 1-2), GOLD stage 3-4 (GS 3-4), and formerly GOLD stage 0 ("at risk")]. The "at risk" group had an average of 14.4 (SD = 30.5) outpatient visits/year and 0.3 (SD = 0.8) hospitalizations/year, which were higher than the other groups, but this was not statistically significant. Respiratory medications were used by 6 (26%), 30 (59%), and 40 (91%) patients from "at risk" to GS 3-4, respectively. Patients in the "at risk" group had a decrement in health status, significant utilization of healthcare services, and were often receiving medications not consistent with guidelines.
AB - Global Initiative on Chronic Obstructive Lung Disease (GOLD) guidelines recently removed stage 0, a group with symptoms but without airways obstruction, from their severity staging. However, in practice this group may still be diagnosed and medically managed. The aim of this study was to characterize healthcare utilization patterns of chronic obstructive pulmonary disease (COPD) patients by disease severity, focusing on the possible unique attributes of patients who would have been classified as GOLD stage 0. This is a prospective cohort pilot study performed at the Hines Veterans Administration Hospital. One hundred twenty patients with a diagnosis of COPD were enrolled. The participants completed quality-of-life questionnaires and a pulmonary function test. Healthcare utilization data were obtained 1 year prior and 2 years after the enrollment date. Three disease severity groups were defined based on GOLD criteria for comparison [GOLD stage 1-2 (GS 1-2), GOLD stage 3-4 (GS 3-4), and formerly GOLD stage 0 ("at risk")]. The "at risk" group had an average of 14.4 (SD = 30.5) outpatient visits/year and 0.3 (SD = 0.8) hospitalizations/year, which were higher than the other groups, but this was not statistically significant. Respiratory medications were used by 6 (26%), 30 (59%), and 40 (91%) patients from "at risk" to GS 3-4, respectively. Patients in the "at risk" group had a decrement in health status, significant utilization of healthcare services, and were often receiving medications not consistent with guidelines.
KW - Chronic obstructive pulmonary disease
KW - Health services research
KW - Health status
KW - Healthcare
UR - http://www.scopus.com/inward/record.url?scp=52449132038&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=52449132038&partnerID=8YFLogxK
U2 - 10.1007/s00408-008-9095-5
DO - 10.1007/s00408-008-9095-5
M3 - Article
C2 - 18463921
AN - SCOPUS:52449132038
SN - 0341-2040
VL - 186
SP - 307
EP - 312
JO - Lung
JF - Lung
IS - 5
ER -